跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
B-7-A
首页
药物
B-7-A
B-7-A
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
TABLET COMPRISING 7-[4-(4-BENZO[b]THIOPHEN-4-YL-PIPERAZIN-1-YL) BUTOXY]-1H-QUINOLIN-2-ONE OR A SALT THEREOF
EP 2767285 B2
申请人: OTSUKA PHARMA CO LTD
优先权: 2011
CN
EP
US
WO
14 件公开
PROCESS FOR THE PREPRATION OF 7-(4,7-DIAZASPIRO[2.5]OCTAN-7-YL)-2-(2,8-DIMETHYLIMIDAZO[1,2-B]PYRIDAZIN-6-YL)PYRIDO[1,2-A]PYRIMIDIN-4-ONE DERIVATIVES
EP 4663641 A3
申请人: HOFFMANN LA ROCHE
优先权: 2017
CN
EP
US
WO
9 件公开
Treatment of SMA
US 11534444 B2
申请人: HOFFMANN LA ROCHE
优先权: 2017
CN
EP
US
WO
9 件公开
NEW FORMS OF PYRIDO[1,2-A]PYRIMIDIN-4-ONE DERIVATIVES, ITS FORMULATION AND ITS PROCESS OF MAKING
EP 3867256 A1
申请人: HOFFMANN LA ROCHE
优先权: 2018
CN
EP
US
WO
8 件公开
Process for preparing modulators of cystic fibrosis transmembrane conductance regulator
US 8344147 B2
申请人: VERTEX PHARMA
优先权: 2010
CN
US
8 件公开
Enhancer for T-cells or B-cells having memory function, malignant tumor recurrence inhibitor, and inducer for inducing memory function in T-cells or B-cells
US 11617765 B2
申请人: UNIV YAMAGUCHI
优先权: 2017
CN
EP
US
WO
7 件公开
Injectable formulation
CN 104363912 A
申请人: OTSUKA PHARMA CO LTD
优先权: 2012
CN
US
7 件公开
Chimeric cytokine of IL-7 and beta-chain of HGF and methods of use
US 7578998 B2
申请人: UNIV CONNECTICUT
优先权: 2001
US
7 件公开
PROCESS FOR PREPARING RISDIPLAM
EP 4308578 A2
申请人: HOFFMANN LA ROCHE
优先权: 2021
CN
EP
US
WO
5 件公开
USE OF 7-CHLORO-N,N,5-TRIMETHYL-4-OXO-3-PHENYL-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-B] INDOLE-1-ACETAMIDE AS A BIOMARKER OF PERIPHERAL BENZODIAZEPINE RECEPTOR LEVELS
US 2012039816 A1
申请人: BENAVIDES JESUS
优先权: 2008
CN
EP
US
5 件公开
第 1 / 10 页
上一页
下一页
药物
反馈